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The facultative pathogen Vibrio cholerae can
exist in both the human small bowel and in
aquatic environments. While investigation of
the infection process has revealedmany factors
important for pathogenesis, little is known re-
garding transmission of this or other water-
borne pathogens. Using a temporally controlled
reporter of transcription, we focus on bacterial
gene expression during the late stage of infec-
tion and identify a unique class of V. cholerae
genes specific to this stage. Mutational analysis
revealed limited roles for these genes in infec-
tion. However, using a host-to-environment
transition assay, we detected roles for six of
ten genes examined for the ability of V. cholerae
to persist within cholera stool and/or aquatic
environments. Furthermore, passage through
the intestinal tract was necessary to observe
this phenotype. Thus, V. cholerae genes ex-
pressed prior to exiting the host intestinal tract
are advantageous for subsequent life in aquatic
environments.
INTRODUCTION
Cholera is caused by the Gram-negative bacterium Vibrio
cholerae (Koch, 1884). This facultative pathogen resides in
two dissimilar habitats: aquatic ecosystems and the
human gastrointestinal (GI) tract. The ability to survive
harsh conditions in the GI tract is facilitated by the in situ
induction of genes, as well as by the induction of genes
in previous cholera victims that increase the infectivity of
V. cholerae during transmission (Butler et al., 2006; Merrell
et al., 2002). V. cholerae usesmotility tomake contact with
the small bowel epithelium (Freter et al., 1981) whereupon
lipopolysaccharide (LPS) and the carbohydrate binding
protein GbpA aid in attachment to the lumenal surface
(Benitez et al., 1997; Kirn et al., 2005; Schild et al.,
2005). Later in infection, cholera toxin (CT) is expressed,264 Cell Host & Microbe 2, 264–277, October 2007 ª2007 Elsevcausing a massive secretory diarrhea that can lead to
hypotensive shock and death within 12 hr of the onset of
symptoms (Bennish, 1994). The diarrhea aids in expulsion
of bacteria from the infected host thereby facilitating
transmission to new hosts.
A variety of V. cholerae colonization factors have been
identified and characterized using the infant mouse and
rabbit ligated ileal loop models of infection. These include
the toxin-coregulated pilus (TCP), accessory colonization
factors, outer membrane porins, and LPS (Reidl and
Klose, 2002). Induction of TCP, CT, and other virulence
factors during infection is dependent on two transmem-
brane regulators ToxR and TcpP and on cytoplasmic reg-
ulators AphA/B and ToxT (Reidl and Klose, 2002).
It was recently shown that virulence gene expression is
also modulated by the intracellular second messenger
cyclic diguanylate (c-di-GMP), whereby low levels of
c-di-GMP lead to increased toxT expression and thus,
virulence gene activation (Tischler and Camilli, 2005). In
addition, quorum sensing regulates virulence gene ex-
pression. At high cell density in the late stage of infection,
virulence genes are repressed while the HapA protease
involved in detachment from the epithelium is induced.
This inverse regulation is mediated by the regulator
HapR (Zhu et al., 2002) whose expression, in turn, is con-
trolled by the Lux quorum-sensing system. However,
since virulent V. cholerae strains with null mutations in
hapR have been isolated (Joelsson et al., 2006), the func-
tion of HapR is not required for pathogenesis.
Upon being shed by humans into aquatic ecosystems,
V. cholerae faces nutrient limitation and shifts in tempera-
ture and osmolarity. In the environment, it is believed that
V. cholerae is associated primarily with phytoplankton,
zooplankton, crustaceans, and insect egg masses (Reidl
and Klose, 2002). The mannose-sensitive hemagglutinin
(MSHA), a type IV pilus, has been shown to promote ad-
herence to the chitinous surfaces of aquatic organisms
(Chiavelli et al., 2001), and other adherence factors like
GbpA and PilA have also been implicated in this process
(Kirn et al., 2005;Meibom et al., 2004). Recently, an impor-
tant regulon in chitin utilization was identified, which in-
cludes secreted chitinases, a chitoporin, and uptake sys-
tems for breakdown products of chitin that serve asier Inc.
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Roseman, 2004;Meibomet al., 2004). Additionally, persis-
tence of V. cholerae in the environment is likely aided by
the formation of surface-attached communities called bi-
ofilms (Watnick and Kolter, 1999; Yildiz and Schoolnik,
1999). Biofilm formation is favored by high levels of c-di-
GMP and is therefore inversely regulated with virulence
genes (Tischler and Camilli, 2004). The concentration of
c-di-GMP is controlled by the opposing activities of digua-
nylate cyclases (GGDEF proteins) and phosphodiester-
ases (Romling and Amikam, 2006).
While much has been revealed regarding the environ-
mental persistence of V. cholerae and its transition from
the environment into the GI tract, little is known about
the equally important reverse transition. Recent studies
indicate that V. cholerae leaves the host in a hyperinfec-
tious state and that the transcriptome of human-shed
V. cholerae differs substantially from in vitro grownV. chol-
erae (Alam et al., 2005; Butler et al., 2006; Merrell et al.,
2002). Using the rabbit ileal loop model, in which V. chol-
erae grows in an anatomically closed compartment, a
distinct phenotype was recently described whereby V.
cholerae undergo a stationary growth-phase-controlled
detachment from the mucosal surface into the lumen
(Nielsen et al., 2006).
We wished to explore in greater detail the physiology
and virulence of V. cholerae during late stages of infection
prior to its transition into aquatic environments using
a more natural, anatomically open intestinal system. Spe-
cifically, we asked whether V. cholerae expresses genes
late in the infection of infant mice that either facilitate
exit from the host or enhance subsequent survival in
aquatic environments. There exist several methods to
identify genes expressed during infection (Chiang and
Mekalanos, 1998; Hang et al., 2003; Merrell et al., 2002;
Nielsen et al., 2006; Xu et al., 2003). We used a variant
of one of these, called recombination-based in vivo ex-
pression technology (RIVET), which functions as a genetic
switch reporter of gene induction (Camilli et al., 1994). The
temporal expression patterns of several of the identified
in vivo induced genes of V. cholerae have been studied in
detail and shown to have an early induction within the first
5 hr of infection of mice (Lee et al., 1998, 1999). In this
report, we adapt RIVET to specifically identify V. cholerae
genes induced at later times of infection. Although some
of these late genes are shown to play roles in fitness within
the GI tract, the majority are dispensable for infection.
Instead, we observed that many late genes enhance the
fitness of V. cholerae in aquatic environments, indicating
that this pathogen initiates a program of gene expression
late in the infection that augments survival upon entry into
aquatic environments.
RESULTS
Identification of Late Genes
The RIVET is used to identify genes expressed during in-
fection based on the TnpR resolvase-mediated excision
of a gene reporter cassette flanked by res sequencesCell Host(Figure 1A; Camilli and Mekalanos, 1995). To identify
V. cholerae genes that are transcriptionally induced late
in the infection, we used a previously constructed plasmid
library containing random genomic fragments inserted
Figure 1. RIVET Screen for Late Genes
(A) Illustration of the genetic components of RIVET (Osorio et al., 2005).
Chromosomal sequences are in gray, pIVET parts are in black, and
the res-cassette parts are in open shapes. pIVET is integrated into
V. cholerae hypothetical geneX via homologous recombination result-
ing in a merodiploid in which geneX and tnpR (resolvase) are transcrip-
tionally fused and controlled by the chromosomal promotor of geneX.
The mobilization (mob), origin of replication (oriR6K), and ApR (bla)
regions of pIVET, as well as the gene for KnR (neo), SucS (sacB), and
the target sites of resolvase (res) of the res-cassette are indicated.
(B) Shown are the medians of recovered KnR (boxes) and KnS (circles)
bacteria at 24 hr postinfection. The different amounts of Kn given at
7 hr postinfection are indicated on the x axis. R10 mice from three
independent experiments comprise each data set. Error bars indicate
interquartile ranges. There was a significant decrease in colonization
for the KnS strain compared to the PBS control for Kn concentrations
R 0.35 mg/kg bw (p < 0.01 using a Kruskal-Wallis test and a posthoc
Dunn’s Multiple comparisons), whereas the KnR bacteria were unaf-
fected (p > 0.05 using a Kruskal-Wallis test). Asterisks indicate the level
of KnS bacteria was below detection limit of 1 CFU for some animals,
but in order to plot the data, the CFU/ml were set to 1.
(C) Competition indices (CI) at 24 hr postinfection from the small bowel
of infant mice. Four hours before infection, mice were given orally the
same concentrations of Kn used in Panel B. Each circle represents the
CI from a single animal. Horizontal bars indicate the median of each
data set. Only the 3.5 mg/kg bw data set is significantly different
from the PBS control (p < 0.01 using tests in panel B legend).& Microbe 2, 264–277, October 2007 ª2007 Elsevier Inc. 265
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bilization of this library into a res-cassette containing V.
cholerae strain results in homologous recombination into
the genome and thus, the generation of random transcrip-
tional fusions of chromosomal genes to tnpR. Induction of
a tnpR fusion leads to excision and loss of the res-cassette
containing two reporter genes: neo and sacB, which con-
fer kanamycin resistance (KnR) and sucrose sensitivity
(SucS), respectively. Therefore, the loss of the res-cas-
sette can be monitored by a phenotypic change to KnS
and SucR. Because we were interested in the later stages
of infection when cell density may be high, we used the
HapR+ V. cholerae strain E7946, hereafter referred to as
AC53 (Miller et al., 1989; Vance et al., 2003).
Induction of tnpR fusions early during infection leads to
KnS bacteria appearing early, whereas strains with unin-
duced tnpR fusions remain KnR. Therefore, to remove all
strains harboring early gene-tnpR fusions, mice were
treated with Kn at 7 hr postinfection. This time point is after
attachment and other early colonization events have oc-
curred, including the induction of known virulence genes
such as ctxAB and tcpA (Angelichio et al., 2004), which en-
code CT and the TCP pilin subunit, respectively. The early
induction of these genes was confirmed for the strain used
in this study (Table 1). The removal of early gene-tnpR
fusion strains demands a certain Kn concentration that
can reduce the number of KnS, but not KnR, bacteria with-
out remaining active in the small bowel over a long period.
To identify such a concentration, mice were infected with
a 1:1mixture of KnR:KnS V. cholerae followed by treatment
at 7 hr with Kn at various concentrations. The number of V.
cholerae colony-forming units (CFU) recovered from the
small bowel at 24 hr are shown in Figure 1B. As expected
in the PBS control group, the KnR and KnS strains colo-
nized and proliferated equally well. With increasing
amounts of Kn the KnS CFU decreased, eventually falling
over a million-fold to %1. This occurred for 3/11 mice in
the 1.4 mg/kg body weight (bw) and for 8/10 mice in the
3.5 mg/kg bw groups. In contrast, the KnR CFU recovered
did not change at any of the Kn concentrations used, im-
plying that colonization of KnR bacteria was unaffected.
To address how long the Kn remains active in vivo, we
treated mice with Kn or PBS 4 hr prior to infection with
a 1:1 mix of KnR:KnS strains. The results expressed as
a competitive index (CI) (KnR/KnS CFU) are shown in Fig-
ure 1C. The median CI for the PBS control group and
the groups treated with Kn up to 1.4 mg/kg bwwas1, in-
dicating no significant effect on colonization of either
strain. However, 3.5 mg/kg bw caused a 25-fold decrease
in colonization of the KnS strain, indicating that Kn was still
active in the small bowel at the time of infection.
Taken together, these experiments revealed that
1.4 mg/kg bw is an optimal Kn concentration, allowing
a 1000-fold reduction of the KnS bacteria without affecting
the colonization of KnR bacteria and not remaining active
longer than 4 hr after application. Therefore, this concen-
tration was chosen for the RIVET screen for late genes. A
total of 12,000 tnpR fusion strains were screened in mice.
After sequencing the genomic insertion site of tnpR in266 Cell Host & Microbe 2, 264–277, October 2007 ª2007 Elsev200 resolved strains, we identified 116 fusions to differ-
ent genes. For 107 of these, we were able to recover the
integrated plasmid containing the tnpR-fusion, which we
then used to reconstruct the original unresolved strain.
To eliminate false positives, we assayed resolution of the
reconstructed strains after 8 hr growth in Luria broth
(LB). Nineteen of the reconstructed strains gave an in vitro
resolution of R50% and were not tested in vivo (herein
in vivo refers to mouse infection). Seventy-nine of the re-
maining 88 gene fusions were plus stranded and were
tested for resolution in vivo. Sixty-two of the fusions
gave an in vivo resolutionR2-fold higher than that in vitro
and were considered to be infection induced (Table 1).
We determined the time interval of late gene induction
in vivo. To compare the resolution data to previously known
early genes, we included tnpR fusions to ctxA and tcpA,
which resolve to >90% within the first 5 hr (Table 1; Lee
et al., 1999). In contrast to ctxA and tcpA, most of the fu-
sions identified in this screen showed a low or moderate
in vivo resolution at 5 or 7 hr compared to at 24 hr. Late
genes were defined by a R2-fold increase in resolution
in vivo from 7 to 24 hr or from 5 to 24 hr. Fifty-seven fusions
fulfilled these requirements, whereas 5 fusions already
showed high expression levels at 5 hr and were designated
early genes (Table 1). Fourteen of the late genes are hypo-
thetical or conserved hypothetical, 14 are predicted to be
involved in metabolic pathways, 10 are associated with
transport systems, 3 are putative transcriptional regula-
tors, 2 are implicated in motility, and 4 are involved (or
are within operons involved) in c-di-GMP metabolism.
Quantitation of Induction of Late Genes
To confirm and quantify the in vivo induction of late genes
identified in our screen, we measured steady-state tran-
script levels by quantitative real-time RT-PCR (qRT-PCR).
Wemeasured the expression of VCA0980 as a representa-
tive of late genes that play roles in colonization, as well as
six late genes that play roles in fitness in stool and/or
pond water (see below). All but one of the genes tested
show a significant increase in transcript level in vivo com-
pared to in vitro (Figure 2A). The 2-fold increase observed
for VC0612 was not significant. However, since this is the
penultimate gene of a large operon (Alm et al., 2005; Mei-
bom et al., 2004), we also measured the transcript level
for the predicted first gene in the operonVC0620,which re-
vealed a 7-fold in vivo induction over in vitro. The in vivo in-
duction of the other genes ranged from3-fold for VCA0686
to300-fold forVCA0601. Inorder toeliminate thepossibility
that the observed gene regulation is strain specific, we
also obtainedqRT-PCRdata on three late genes in another
V. cholerae strain AC51, whichwas isolated from a cholera
patient in a different continent (Figure 2B). The results show
that these late genes are induced in vivo at a magnitude
similar to that observed for strain AC53.
Roles of Late Genes in Infection
To investigate if some of the identified late genes are in-
volved in colonization of the infant mouse small bowel,
we constructed in-frame deletions of 22 genes and testedier Inc.
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in in vivo and in vitro competitions. Interestingly, only three
mutants had an in vivo defect (Figure 3A; Figure S1A in the
Supplemental Data available with this article online; data
not shown). Two of these, DVCA0920 and DVCA0980, ex-
hibited a 2- to 3-fold colonization defect at 24 hr, but not at
7 hr nor in vitro. Expression of the respective genes in trans
rescued colonization for both mutants. The third, VC0201,
is the ATPase component of a ferrichrome transport sys-
tem (Rogers et al., 2000). Deletion of this gene resulted
in a 40-fold colonization defect at 24 hr, but only a mild
3-fold defect at 7 hr. Expression of VC0201 in trans gave
a partial rescue of the defect. Although we did not directly
hit VC0201 in our screen, it is in an operon with the identi-
fied VC0203, which encodes the permease component of
the transport system. This same operon was recently
found to be induced during human infection as well
(M.-J. Lombardo, J.Michalski, H.Martinez-Wilson, C.Morin,
T. Hilton, C.G. Osorio, J.P. Nataro, C.O. Tacket, A.C., and
J.B. Kaper, unpublished data). Interestingly, the coloniza-
tion defect of all three late gene mutants was most pro-
nounced late in the infection. This stands in contrast to
the early gene tcpA mutant where there is already a mas-
sive 400-fold attenuation by 7 hr (Figure 3B) and the defect
increases only another 25-fold between 7 and 24 hr.
Roles of Late Genes in Metabolism
The predicted functions for three of the late genes sug-
gested phenotypes that could be tested in vitro. These in-
clude VC1926, annotated as a C4-dicarboxylate transport
transcriptional regulator, and VCA0744, which shows
79.5% amino acid identity to a glycerol kinase of Escher-
ichia coli. VC1926 is predicted to form a two component
system with VC1925. By analogy to an orthologous sys-
tem in Rhodobacter capsulatus, VC1926 should act as
an activator of the cis dctPQM operon (VC1927-9) encod-
ing a putative transporter of malate, succinate and fuma-
rate (Forward et al., 1997; Hamblin et al., 1993). To deter-
mine the functions of VC1926 and VCA0744 in carbon
acquisition we competed the respective mutants against
AC53res1 in M9 minimal medium (M9) with various sole
carbon sources (Figures 4A and 4B). DVC1926 grew nor-
mally inM9 plus glycerol (Gly) but was defective for growth
in M9 plus the C4-dicarboxylate succinate. In contrast,
DVCA0744 failed to grow in M9 plus Gly but grew in M9
plus glucose (Glc). The observed growth defects could
be complemented by expression of VC1926 or VCA0744
in trans. Furthermore, VC0612 was identified to be a late
gene (Table 1), which encodes an ortholog of a Vibrio
furnissii cytoplasmic N,N-diacetylchitobiose phosphory-
lase (Park et al., 2000). However, a DVC0612 strain shows
only a mild growth defect in M9 plus chitin (Figure 4C).
Since the upstream gene VC0613 encodes an ortholog
of a V. furnissii periplasmic b-N-acetylglucosaminidase
(Keyhani and Roseman, 1996), we tested the DVC0612-
3 double mutant and observed a 40-fold attenuation in
M9 plus chitin (Figure 4C). Expression of VC0612 in trans
in the double mutant partially rescued the phenotype. As
expected, the double mutant grows normally if Gly orCell Host &N-acetylglucosamine (GlcNAc) is given as a carbon
source. The growth defect of DVC0612-3 is consistent
with induction of this operon in V. cholerae in the presence
of chitin or GlcNAc-oligomers and with their predicted
role in utilization of the chitin-derived substrates chito-
biose (GlcNAc2) and GlcNAc-oligomers (Meibom et al.,
2005).
Roles of Late Genes in the Transition
to Aquatic Environments
Since most of the late genes did not play a detectable role
in colonization ormaintenance of the infection, we hypoth-
esized that some of these genes may play a role in transi-
tioning to aquatic environments, and furthermore, that
preinduction of those genes late in infection may provide
a fitness advantage when the bacterium encounters the
aquatic environment. To test this hypothesis, we pas-
saged AC53res1 and late gene deletion mutants in single
strain infections. At 24 hr, bacteria were harvested from
the small bowels, and mutant and AC53res1 were mixed
1:1. This mix was used as the inoculum in a variety of sur-
vival and growth assays.We focused on two different con-
ditions V. cholerae is likely to face after detaching from the
small bowel epithelium: a short incubation in rice-water
stool and a longer persistence in pondwater. We detected
a 2- to 3-log drop in CFU after the 2 hr incubation in stool
indicating this is a hostile environment. In contrast, the
recovered CFU after 24 hr incubation in pond water
were similar to the input CFU, and in LB or M9 plus Gly
the bacteria multiplied 10,000-fold.
Figure 5 displays the results obtained fromcompetitions
of six late gene mutants, for which we obtained the clear-
est phenotypes out of ten tested. These includeDVC1926,
DVCA0744, and the DVC0612-3 double mutants (Figures
5A–5C, respectively) described above. In addition, we
tested mutants of VCA0686 and VCA0601 (Figures 5D
and 5E), both annotated as permeases in putative
FeSO4 uptake systems, and a triple mutant of three late
genes encoding GGDEF proteins (Figure 5F). Although
VC2370 was not a direct hit in our screen, the flanking
genes VC2369 and VC2371, within the same operon,
were identified to be late in vivo induced. The observed
phenotypes for the GGDEF mutants increased from a sin-
gle to the triple mutant, and therefore only the data for the
triple mutant is shown. The DVCA0601 and triple GGDEF
mutants had a respective 2- and 3-fold survival defect
after 2 hr incubation in stool compared to LB (Figures 5E
and 5F). In addition, all six mutants exhibited a significant
fitness defect in pond water after 24 hr. The attenuation
ranged from 4-fold for DVC1926 (Figure 5A) to 10-fold
for DVCA0601 (Figure 5E). None of the phenotypes in
pond water were observed in LB or M9 plus Gly except
for the DVCA0744 glycerol kinase mutant, which was
attenuated in the latter medium as expected (Figure 5B).
In addition, we competed the late gene mutants with
AC53res1 after in vivo passage in a reinfection assay.
None of the six late gene mutants demonstrated any sig-
nificant defect in this second round of infection (Fig-
ure S1B). In all cases, the observed defects of theseMicrobe 2, 264–277, October 2007 ª2007 Elsevier Inc. 267
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Gene
Locusb Operonc
Annotation/Gene
Symbolb
Resolution in %a
Median
(in vitrod)
in vivo
Median
(21 hr)/
Median
(in vitro)e
Median
(21 hr)/
Median
(7 hr)e
Median
(21 hr)/
Median
(5 hr)
Median
(5 hr)
Median
(7 hr)
Median
(21 hr)
Early infection-induced control genes
VC0828 toxin coregulated pilin (tcpA) 0.9 99.0 98.5 NDf ND ND ND
VC1457 VC1456–7 cholera enterotoxin, A subunit
(ctxA)
8.5 91.5 98.9 ND ND ND ND
Late infection-induced genes - (Median 21 hr/Median 7 hr) > 2
VC0044 VC0041–6 sun protein (sun) 26.1 ND 8.6 61.1 2.3 7.1 ND
VC0130 GGDEF family protein 0 ND 2.3 63.9 63.9 27.7 ND
VC0203 VC0200–3 iron(III) ABC transporter,
permease protein
18.9 ND 13.3 79.9 4.2 6 ND
VC0280 VC0280–1 cadaverine/lysine antiporter
CadB, putative
0 ND 0 28.3 28.3 28.3 ND
VC0353* conserved hypothetical protein,
40 bp to VC0351 onminus strand
1.1 ND 1.2 50 47.2 42.4 ND
VC0376 conserved hypothetical protein 2 ND 2.9 19 9.5 6.6 ND
VC0384 VC0383–6 sulfite reductase (NADPH)
flavoprotein alpha-component
(cysJ)
14 ND 14.8 50.9 3.6 3.4 ND
VC0404 VC0398–414 MSHA biogenesis protein MshN 42.4 ND 39.9 93.6 2.2 2.3 ND
VC0426 hypothetical protein 14.5 ND 5.7 54.3 3.7 9.5 ND
VC0554 VC0553–4 protease, insulinase family-
protease, insulinase family
1.5 ND 5.3 75.3 51.2 14.3 ND
VC1093 VC1091–5 oligopeptide ABC transp.,
permease (oppC)
1.4 ND 0 75.4 55.8 75.4 ND
VC1169 VC1169–75 tryptophan synthase, alpha
subunit (trpA)
0.9 ND 20.7 84.7 92.1 4.1 ND
VC1212* DNA polymerase II (polB),
overlap to VC1211
0 ND 5.8 30.9 30.9 5.3 ND
VC1317 conserved hypothetical protein 6.6 ND 4.3 53.9 8.2 12.6 ND
VC1822 PTS system, fructose-specific
IIABC component (frwABC)
20.4 ND 19.9 85.3 4.2 4.3 ND
VC1906 hypothetical protein 5.8 ND 3.3 30.3 5.2 9.1 ND
VC1926 VC1924–6 C4-dicarboxylate transport
transcriptional regulatory protein
(dctD-1)
7.1 ND 5.3 78 10.9 14.8 ND
VC1975 VC1971–6 2-oxoglutarate decarboxylase/
2-succinyl-6-hydroxy-2,4-
cyclohexadiene-1-carboxylate
synthase (menD)
1.4 ND 47.3 99.5 70.1 2.1 ND
VC2072* peptidase, insulinase family,
overlap to VC2073 on minus
strand
5.6 ND 0 51.6 9.2 51.6 ND
VC2118 adenine-specific methylase,
putative
2.7 ND 0 12.9 4.9 12.9 ND
VC2161 methyl-accepting chemotaxis
protein
13.7 ND 3.9 35.9 2.6 9.2 ND
VC2167 VC2164–7 hypothetical protein 0 ND 30.2 67.1 67.1 2.2 ND268 Cell Host & Microbe 2, 264–277, October 2007 ª2007 Elsevier Inc.
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Gene
Locusb Operonc
Annotation/Gene
Symbolb
Resolution in %a
Median
(in vitrod)
in vivo
Median
(21 hr)/
Median
(in vitro)e
Median
(21 hr)/
Median
(7 hr)e
Median
(21 hr)/
Median
(5 hr)
Median
(5 hr)
Median
(7 hr)
Median
(21 hr)
VC2209 nonribosomal peptide
synthetase VibF, authentic
frameshift (vibF)
7.6 ND 1.7 15.4 2 9.1 ND
VC2294 VC2288–95 NADH:ubiquinone
oxidoreductase
20 ND 25.9 78.3 3.9 3 ND
VC2300 AmpG protein, putative 39.3 ND 10.5 88.9 2.3 8.4 ND
VC2369 VC2369–71 sensor histidine kinase FexB
(fexB)
7.3 ND 31.8 66.2 9.1 2.1 ND
VC2376 VC2376–7 glutamate synthase, large
subunit (gltB-2)
49.43 ND 49.01 98.93 2.0 2.0 ND
VC2538 VC2537–9 thiamine transport system
permease protein
37.3 ND 25 85.3 2.3 3.4 ND
VC2697 GGDEF family protein 13.9 ND 2.3 57.9 4.2 25.3 ND
VC2739 conserved hypothetical protein 3.9 ND 0.6 43.1 11.2 74.4 ND
VCA0033 hypothetical protein 1.6 ND 4.2 21.8 13.9 5.2 ND
VCA0043 conserved hypothetical protein 6.8 ND 2.1 60.5 8.9 29.5 ND
VCA0083 multidrug resistance protein D
(emrD-1)
37.4 ND 32.3 94.3 2.5 2.9 ND
VCA0182* sigma-54 dependent
transcriptional regulator,
VCA0181 on minus
1.4 ND 8.6 55.7 40.4 6.5 ND
VCA0183 ferrisiderophore reductase
(hmpA)
6.3 ND 3.7 25 4 6.7 ND
VCA0630 VCA0630–1 D-isomerspecific 2-hydroxyacid
dehydrogenase family protein
37.3 ND 12.7 92.5 2.5 7.3 ND
VCA0686 VCA0685–7 iron(III) ABC transporter,
permease protein
1.6 ND 12 46.3 29.8 3.9 ND
VCA0744 glycerol kinase (gplK) 7.5 ND 8.6 26.7 3.6 3.1 ND
VCA0766 VCA0764–6 cytochrome c554 2.2 ND 6 17.7 8.2 3 ND
VCA0907 VCA0907–9 heme-binding protein HutZ
(hutZ)
3.6 ND 0 32 9 32 ND
VCA0920 conserved hypothetical protein 6.3 ND 6 47.9 7.6 8 ND
VCA0955 transcriptional regulator, MarR
family
7.1 ND 9.2 69.2 9.8 7.5 ND
VCA0956* GGDEF family protein, 100bp to
VCA0957 on minus strand
9 ND 1 26.6 2.9 28 ND
VCA0980 hypothetical protein 2.4 ND 8.8 67.3 28.1 7.6 ND
VCA1046 VCA1045–7 mannitol-1-phosphate
5-dehydrogenase (mtlD)
21.4 ND 7.7 68.8 3.2 8.9 ND
VCA1071 VCA1071–2 sodium-proline symporter (putP) 18.6 ND 12.4 68.2 3.7 5.5 ND
VCA1110 VCA1105–11 long-chain-fatty-acid-CoA
ligase, putative
3.2 ND 3.6 12.3 3.9 3.5 ND
VCA1115* ParA family protein, 100 bp
to VCA1113 on minus strand
0 ND 8.6 72.8 72.8 8.5 ND
(Continued on next page)Cell Host & Microbe 2, 264–277, October 2007 ª2007 Elsevier Inc. 269
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Gene
Locusb Operonc
Annotation/Gene
Symbolb
Resolution in %a
Median
(in vitrod)
in vivo
Median
(21 hr)/
Median
(in vitro)e
Median
(21 hr)/
Median
(7 hr)e
Median
(21 hr)/
Median
(5 hr)
Median
(5 hr)
Median
(7 hr)
Median
(21 hr)
Late infection-induced genes - (Median 21 hr/Median 5 hr) > 2
VC0612 VC0611–20 cellulose degradation product
phosphorylase
28.0 6.5 43.8 75.0 2.7 1.7 11.5
VC1593 VC1592–3 GGDEF family protein 8.8 7.5 76.5 94.1 10.7 1.2 12.5
VC2191 VC2190–200 flagellar hook-associated
protein FlgM
13.4 5.4 47.4 88.4 6.6 1.9 16.5
VC2330 conserved hypothetical protein 9.8 3.1 16.7 21.4 2.2 1.3 7.0
VC2371 VC2369–71 conserved hypothetical protein 12.7 22.3 86.8 98.8 7.8 1.1 4.4
VC2621 hypothetical protein 0.0 3.4 51.7 90.1 90.1 1.7 26.4
VCA0601 VCA0601–2 ABC transporter, permease
protein
6.2 1.3 53.8 88.2 14.3 1.6 66.0
VCA0756 transcriptional regulator, LysR
family
3.0 7.6 10.1 17.3 5.8 1.7 2.3
VCA0985 VCA0984–5 oxidoreductase-iron-sulfur
cluster-binding protein
13.0 22.3 43.3 88.0 6.7 2.0 3.9
Early infection-induced genes - (Median 21 hr/Median 5 hr) < 2
VC0066 VC0061–6 thiH protein (thiH) 7.3 48.2 60.0 78.6 10.8 1.3 1.6
VC1667 VC1664–7 conserved hypothetical protein 48.1 64.5 73.8 97.9 2.0 1.3 1.5
VC1687 VC1686–7 conserved hypothetical protein 27.9 93.2 92.3 94.3 3.4 1.0 1.0
VC1692 VC1692–94 trimethylamine-N-oxide
reductase (torA)
6.6 93.7 93.8 92.0 14.0 1.0 1.0
VC2712 xanthine-uracil permease
family protein
18.2 89.7 96.5 100.0 5.5 1.0 1.1
Shown are medians of the percent resolution for individual gene-tnpR fusion strains in each condition and/or time point of at least
three independent resolution assays. Also shown are ratios of in vivo/in vitro resolution medians. The criteria used to define early
versus late genes are listed. Each group is sorted by the gene locus.
a Percentage of resolution is given by the amount of SmR/KnS CFU (given by SmR/ApR CFU minus SmR/KnR CFU) divided by the
amount of SmR/ApR CFU.
bGene locus and annotation/gene symbol according to The Institute of Genomic Research TIGR (http://cmr.tigr.org/tigr-scripts/
CMR/GenomePage.cgi?database=gvc).
c Operon prediction according to http://www.microbesonline.org/operons/gnc666.named (Alm et al., 2005).
d Percentage of resolution after 8 hr growth in LB with aeration.
e In cases where the median of the divisor would be 0 it was set to 1 to allow calculating ratios of the medians.
f Not determined (ND).
* The orientation of tnpR was the opposite of the transcription of indicated genes; however, genes in the same orientation as tnpR
overlap or are within 100 bp of the insertion site.mutants in stool and pond water could be rescued by ex-
pression of the respective gene in trans (Figures 5A–5F).
All pond water samples usedwere hypoosmolar, having
conductivities 50-fold lower than LB or M9. To test
whether the observed transition phenotypes correlate
with changes in osmolarity, we added 100 mM betaine
or M9 minus a carbon source to an equal volume of
pondwater. In general, all mutants performed better under
these conditions (Figures 5A–5F). However, since most
mutants still retained a significant fitness defect, changes
in osmolarity are not the sole cause of the fitness defects270 Cell Host & Microbe 2, 264–277, October 2007 ª2007 Elsevobserved in pond water. Only the defects of DVCA0601
and DVCA0686 can be fully rescued by adding M9, but
not by adding betaine (Figures 5D and 5E). We also com-
peted each mutant against AC53res1 in 1/50 M9; how-
ever, no significant defect in fitness for any of the mutants
was detected (Figures 5A–5F).
We hypothesized that preinduction of V. cholerae late
genes within the intestinal tract is important for their sub-
sequent roles in stool and pondwater survival. To test this,
in addition to competing late gene mutants with AC53res1
after an in vivo passage, we also performed the assaysier Inc.
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no preinduction had occurred. In contrast to the observed
fitness defects in stool or pondwater after in vivo passage,
none of the six in vitro passaged late gene mutants ex-
hibited any significant attenuation in these assays (Figures
5A–5F) or in LB (data not shown).
DISCUSSION
The major goals of this study were to identify V. cholerae
genes induced in late stages of intestinal infection and
characterize their function in the life cycle of this faculta-
tive pathogen. We chose RIVET in combination with the
infant mousemodel to address these questions for several
reasons. DNA microarrays on bacteria recovered from the
Figure 2. Validation of Late Genes by qRT-PCR
Shown is the ratio of transcripts of the late genes indicated on the
x axis to rpoB (control) in vivo at 24 hr postinfection (filled circles)
and for log-phase in vitro LB cultures (open circles). Each data set
was normalized to one randomly selected in vitro reference sample.
Expression was analyzed in two different V. cholerae strains: (A)
AC53 and (B) AC51. Each circle represents the qRT-PCR result from
an independent culture or mouse output. The horizontal bar indicates
the median of each data set. Except for VC0612, all in vivo data sets
are significant different compared to the respective in vitro data set
(p < 0.05 using a Mann-Whitney U-test).Cell Host &infant mouse small bowel have not been feasible thus far
due to low yield of bacterial RNA and massive contamina-
tion with host RNA. DNA microarray data is available for
the rabbit ileal loop model of cholera (Nielsen et al.,
2006; Xu et al., 2003), a model based on growth of V. chol-
erae in a surgically closed section of the ileum. Although
the ileal loop model may simulate some aspects of the
human infection, it cannot reflect the dynamic progression
of the natural disease in the open GI tract. One striking
point is that, according to both published DNA microarray
data sets, the genes encoding CT are not induced in the
rabbit ileal loop (Nielsen et al., 2006; Xu et al., 2003).
We validated our results by qRT-PCR in two different V.
cholerae strains and by comparing the identified late
genes to previously published data sets of infection-
induced genes. Since our reporter system is based on de-
tection of infection-induced promotors, we searched by
operons containing late genes (Table 1) rather than only
by the genes directly identified by a tnpR fusion. Among
Figure 3. Some Late Gene Mutants Are Attenuated Late in
Infection
Results are shown as the CI at given time points for competitions in LB
and in vivo using the infant mousemodel. Each circle represents the CI
from a single assay. The horizontal bars indicate the median of each
data set. The asterisks indicate significantly different medians of the
compareddata sets indicatedby the linebeloweachasterisk (p<0.01us-
ingaMann-WhitneyU-test). (A)Abbreviations standfor the followingcom-
petitions a, DVCA0920/AC53res1; b, DVCA0920 (pVCA0920)/AC53res1
(pMMB67EH); c, DVCA0980/AC53res1; d, DVCA0980 (pVCA0980)/
AC53res1 (pMMB67EH); e, DVC0201/AC53res1; f, DVC0201 (pVC0201)/
AC53res1 (pMMB67EH). (B) CI for the early infection-induced gene
mutant DtcpA competed against AC53res1 in LB and in vivo.Microbe 2, 264–277, October 2007 ª2007 Elsevier Inc. 271
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strated before to be induced in cholera patient stool sam-
ples (Bina et al., 2003;Merrell et al., 2002), and/or identified
in aRIVET screen in human volunteers (M.-J. Lombardo, J.
Figure 4. In Vitro Growth Defects of Late GeneMutants Using
Specific Carbon Sources
Competition assays performed in M9 minimal media with the carbon
sources indicated. Each circle represents the value from a single com-
petition experiment. The horizontal bar shows the median of each data
set. The asterisks indicate significantly different medians between the
data sets indicated (p < 0.01 using a Mann-Whitney U-test). Abbrevia-
tions stand for the following competitions. (A) a, DVC1926/AC53res1;
b, DVC1926 (pVC1926)/AC53res1 (pMMB67EH). (B) a, DVCA0744/
AC53res1; b, DVCA0744 (pVCA0744)/AC53res1 (pMMB67EH). (C)
a, DVC0612/AC53res1; b, DVC0612-3/AC53res1; c, DVC0612-3
(pVC0612)/AC53res1 (pMMB67EH).272 Cell Host & Microbe 2, 264–277, October 2007 ª2007 ElsevMichalski, H. Martinez-Wilson, C. Morin, T. Hilton, C.G.
Osorio, J.P. Nataro, C.O. Tacket, A.C., and J.B. Kaper, un-
published data). Furthermore 29 of the 57 late gene op-
erons have previously been shown to be induced in animal
models of cholera (Bina et al., 2003; seeTableS4 inNielsen
et al., 2006; see data set 3 in Xu et al., 2003). These findings
suggest that the induction of these late genes is a general
phenomenon in V. cholerae and is likely to be observed in
a human infection. In the rabbit ileal loop model, it has re-
cently been demonstrated that, in the late phase of infec-
tion, the stationary phase sigma factor RpoS, which is un-
der the control of HapR, controls a mucosal escape
process (Nielsen et al., 2006). According to that report,
ten of the late gene operons identified in this study are un-
der the control of RpoS. However, seven of those are re-
pressed by RpoS, suggesting that we identified a distinct
set of genes,maybe due to the different dynamics in the in-
fant mouse compared to the rabbit ileal loop.
Unexpectedly, seven late gene operons were in com-
mon with those reported to be repressed at 12 hr in the
infant mouse model using a FACS-based screen (Hsiao
et al., 2006), including the chitin degradation operon
(VC0611-20) and the MSHA operon (VC0398-414). The
authors did not confirm the in vivo repression of most of
these genes. However, they did provide convincing data
for repression of the MSHA operon and did demonstrate
that constitutive expression of this operon is deleterious
to colonization due to a failed evasion of host immunity.
Repression of the MSHA operon at 12 hr postinfection is
not directly in conflict with our data as we detected an
increase in expression only at the 24 hr time point. Com-
bining these results, we propose that V. cholerae re-
presses this operon in the early- to midstages of infection
to evade host defenses but induces it late in infection to
allow synthesis ofMSHA, which then facilitates adherence
to chitin after release into the environment (Chiavelli et al.,
2001).
Previous studies showed that 25% of infection-in-
duced gene deletion mutants are attenuated in the infant
mouse model (Camilli and Mekalanos, 1995; Osorio
et al., 2005). In contrast, only three out of 22 late gene de-
letion mutants revealed a significant in vivo defect. One
explanation for this difference could be that a competition
assay in infant micemostly queries for colonization early in
the infection. Consequently, the early gene tcpA mutant
lacking TCP shows a massive attenuation early on in the
infection. In contrast, we demonstrated that the attenua-
tion for late gene mutants, if it occurred, was apparent
late in the infection consistent with their late induction.
The majority of the late genes that we identified did not
appear to contribute to infection. Rather, they assist in
preparing the bacterium for the transition to aquatic envi-
ronments. We developed a host-to-pond transition assay
and confirmed this hypothesis for six late genes. In con-
trast, there was no fitness defect when the mutant strains
were grown in vitro and competed in stool and/or pond
water. Thus, we conclude that the induction of these
genes late in infection serves to prepare V. cholerae for
survival in rice-water stool and in aquatic environments.ier Inc.
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Late Infection-Induced Genes of V. choleraeFigure 5. Some Late Gene Mutants Are Attenuated in Stool and/or Pond Water Survival after In Vivo Passage
Competition assays in various conditions using in vivo or in vitro passaged strains as indicated. Each circle represents the value from a single com-
petition assay. The horizontal bar indicates the median of each data set. A significant decrease of the CI compared to that in LB is indicated above the
data sets (*p < 0.01 or **p < 0.05 using a Mann-Whitney U-test). A plus sign indicates a significant difference of the CIs between mutants expressing
the respective gene in trans and AC53res1 with vector alone compared to the mutant/AC53res1 (p < 0.05 using a Mann-Whitney U-test). Abbrevia-
tions stand for the following competitions. (A) a, DVC1926/AC53res1; b, DVC1926 (pVC1926)/AC53res1 (pMMB67EH). (B) a, DVCA0744/AC53res1;
b,DVCA0744 (pVCA0744)/AC53res1 (pMMB67EH). (C) a,DVC0612-3/AC53res1; b,DVC0612-3 (pVC612)/AC53res1 (pMMB67EH). (D) a,DVCA0686/
AC53res1; b, DVCA0686 (pVCA0686)/AC53res1 (pMMB67EH). (E) a, DVCA0601/AC53res1; b, DVCA0601 (pVCA0601)/AC53res1 (pMMB67EH).
(F) a, DVC1593-DVC2697-DVC2370/AC53res1; b, DVC1593-DVC2697-DVC2370 (pGPVC1593-VC2370-VC2697)/AC53lacZ.Cell Host & Microbe 2, 264–277, October 2007 ª2007 Elsevier Inc. 273
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found that the defects of the DVCA0686 and DVCA0601
mutants could be fully restored by adding M9 salts to
pond water. The genes are part of two operons annotated
as FeSO4 uptake systems. However, these annotations
are not supported by recent data demonstrating that the
major regulator of iron homeostasis in Gram-negative
bacteria, Fur, does not control these operons, and expres-
sion of them in a Shigella flexneri strain deficient in iron up-
take fails to rescue growth (Wyckoff et al., 2006). Our data
suggest that these transport systems, rather, facilitate the
uptake of a component of M9 salts. The other four late
gene mutants show only a partial rescue in pond water
when M9 salts or betaine is added, and none of the
mutants was attenuated in diluted, hypoosmotic M9.
Therefore, we conclude that hypoosmolarity is only one
of several stress factors in the transition to pond water.
Carbon sources and their concentrations differ dramat-
ically between the intestinal tract and aquatic environ-
ments. We demonstrated that three late genes mutants
involved in carbon source utilization exhibited a defect in
the transition to pond water. The observed growth defects
of DVC1926 on succinate, DVCA0744 on Gly, and
DVC0612-3 on chitin are consistent with their respective
roles as an activator of C4-dicarboxylate transport, a glyc-
erol kinase and degradation enzymes in the chitin utiliza-
tion pathway, respectively. Although the concentrations
of Gly and the specific C4-dicarboxylate (or precursors)
that would feed into these pathways are unknown, it is
known that chitin is a major carbon source in aquatic
environments (Keyhani and Roseman, 1999). Given the
absence of chitin in mammals, the identification of a chitin
catabolic operon together with the MSHA chitin-binding
pilus operon (Chiavelli et al., 2001) as late genes clearly in-
dicates that V. cholerae prepares its metabolic program
prior to its encounter with this carbon and nitrogen source.
We identified three late genes encoding GGDEF pro-
teins whose expression is predicted to lead to increased
c-di-GMP concentration. It is believed that the concentra-
tion of this signaling molecule in V. cholerae is high in
aquatic environments to facilitate biofilm formation (Tisch-
ler and Camilli, 2004). On the other hand, it is likely that V.
cholerae must reduce the concentration of c-di-GMP
upon entry into the human host since high levels of c-
di-GMP inhibit virulence gene expression (Tischler and
Camilli, 2005). The observed fitness defect for the triple
GGDEF mutant in stool and pond water suggests an im-
portant role for c-di-GMP in the transition from host to
environment. Our data suggest that V. cholerae already
increases the concentration of c-di-GMP inside the host
and not only after release into the environment.
Taken together, our results extend the model of the life
cycle of pathogenic V. cholerae as we propose in Figure 6.
Upon entry into humans, V. cholerae induces early genes
critical for colonization of the small bowel, such as the
biosynthetic genes for TCP. After colonization and prolif-
eration, late genes are induced, which increase fitness in
the late stage of infection and/or in the transition to aquatic
environments. When shed into fresh water, V. choleraewill274 Cell Host & Microbe 2, 264–277, October 2007 ª2007 Elsevexperience a severe drop in osmolarity and carbon source
availability. Large-scale changes to its proteome andmet-
abolic state in response to this harsh environment will be
energetically costly. Thus, the preinduction of V. cholerae
genes in the GI tract that are advantageous for environ-
mental survival provides an overall increase in fitness.
Additionally, the expression of late genes might allow V.
cholerae to hoard factors in the host that are limited in
aquatic environments. Evolution is likely to have selected
for expression of those genes important for transition
while V. cholerae is still in the host. After release in stool,
V. cholerae can either persist for long periods, for exam-
ple, by attaching to surfaces and using chitin as a carbon
and nitrogen source, or it can persist short-term awaiting
ingestion by a new human host. Interestingly, the late
genes identified in this study that are important for envi-
ronmental fitness were found not to be necessary for
a second round of infection and are therefore not involved
in host-passaged hyperinfectivity. However, we cannot
exclude that other late genes play roles in hyperinfectivity,
and this possibility will be investigated in future studies.
As demonstrated in this study, the ability to prepare for
a change in environment enables V. cholerae to better
survive the transition from host to aquatic environment.
To our knowledge, such transition factors have not been
previously described for a facultative pathogen.
EXPERIMENTAL PROCEDURES
Reagents, DNA Manipulations, and Construction of Mutant
and Complemented Strains
Bacterial strains and plasmids are listed in Table S1, and PCR primers
used to construct plasmids are listed in Table S2. Information about
general growth conditions, reagents, standard DNA manipulations,
and strain or library construction methods are stated in the Supple-
mental Data.
Screening for Late Genes
An aliquot of each pool of the library was spread in triplicate on LB-Ap/
Sm/Kn plates. After O/N incubation, 5000 colonies were collected
Figure 6. Model of the Pathogenic V. cholerae Life Cycle
Human infection occurs by ingestion of V. cholerae. Induction of early
genes is crucial for survival and successful colonization of the small
bowel. Induction of late genes allows maintenance of the infection
and increases fitness for the transition step into aquatic environments.
After the release into the environment, V. cholerae can infect a new
human host in a short time period (short-term persistence) or form
associations with chitinous material allowing long-term persistence
in the environment.ier Inc.
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Late Infection-Induced Genes of V. choleraefrom each plate, diluted in LB to106 CFU/ml, and 50 ml used to intra-
gastrically inoculate 5-day-old CD-1 mice (anesthetized by isoflurane)
as previously described (Camilli et al., 1994). Seven hours postinfec-
tion, mice were anesthetized and a Kn dose of 1.4 mg/kg bw in 50 ml
PBS was given intragastrically. Twenty-four hours postinfection,
mice were euthanized, and their small bowels were removed and ho-
mogenized in 1 ml of LB plus 20% Gly. Serial dilutions of the homog-
enate were plated on LB agar lacking NaCl and supplemented with
10% Suc and Sm to select for resolved strains. After incubation O/N
at 30C, eight SucR KnS colonies were picked from each mouse out-
put, grown in LB, and stored at 80C in 96-well plates (Costar) in
LB plus 20% Gly. Gene fusions to tnpR were PCR amplified and
sequenced as described (M.-J. Lombardo, J. Michalski, H. Martinez-
Wilson, C. Morin, T. Hilton, C.G. Osorio, J.P. Nataro, C.O. Tacket,
A.C., and J.B. Kaper, unpublished data). Sequences were compared
to the V. cholerae N16961 genome database (Heidelberg et al.,
2000) with blastN (http://tigrblast.tigr.org/cmr-blast/). We considered
transcriptional fusions of tnpR to any annotated ORF within which it
had inserted in the same orientation, as well as any annotated ORF
in the same orientation lying %100 bp from the RBS of tnpR as long
as no factor-independent transcriptional terminators were present.
Fusion strain reconstructions and quantification of resolution is
described in the Supplemental Data.
Competition Assays
Competition assays in infant mice and in LB broth were performedwith
late gene in-frame deletion mutants (lacZ+) competed for 7 or 24 hr
against the isogenic AC53res1 strain (lacZ) as described (Camilli
and Mekalanos, 1995). Results are shown by the competition index
(CI), which is the ratio of mutant CFU to AC53res1 CFU normalized
for the input ratio. Competitions in M9 with various carbon sources
were done by inoculation of 2 ml of medium with 105 CFU of V. chol-
erae prepared in saline (0.85% NaCl, pH 7.5). The M9 cultures were
incubated 24 hr at 25C.
To show complementation in trans in all assays in this study, deletion
mutants (lacZ+) with the respective pMMB67EH expression derivative
with or without IPTG induction were competed against AC53res1
(lacZ) containing the empty pMMB67EH, with the exception of strain
DVC1593-DVC2697-DVC2370 (pGPVC1593-VC2697-VC2370), which
was competed against AC53lacZ.
RNA Purification and qRT-PCR
RNA was isolated at 24 hr postinfection from small bowels of six mice
infected with V. cholerae and mock-inoculated mice that received
PBS. Small bowels were homogenized in Trizol (1 ml). Following chlo-
roform extraction, ethanol was added to the aqueous phase to a final
concentration of 35% and purified using the RNeasy Mini Kit (QIA-
GEN). RNA was also isolated from six independent midexponential
phase cultures of bacteria grown in LB. DNA was removed using
a DNA-free kit (Ambion). cDNA was synthesized from 1 mg RNA using
SuperScript First Strand Synthesis System for qPCR (Invitrogen).
Controls lacking reverse transcriptase were included.
qRT-PCR experiments were done using Brilliant SYBR Green qPCR
MasterMix (Stratagene). Each reaction contained 300 nMprimers, 100
ng template, and ROX reference dye. The six independent in vivo and
in vitro samples were tested in triplicate. The sequences of the primers
used in these studies are in Table S1, labeled as x-qF and x-qR in
which ‘‘x’’ stands for the respective gene. All primer pairs amplified
the target gene with efficiencies of 97% or greater (data not shown).
For each sample, the mean cycle threshold of the test transcript was
normalized to that of rpoB and to one randomly selected in vitro refer-
ence sample. Values > 1 indicate that the transcript is present in higher
numbers in the test sample than in the in vitro reference.
Transition Assays
The fitness of late gene deletion mutants (lacZ+) in transitioning from
mouse intestinal tract to rice-water stool or pond water was deter-
mined in competition assays against the isogenic AC53res1 strainCell Host(lacZ). Each strain was grown on LB-Sm plates O/N, diluted in LB
to OD600 = 0.002, and used to intragastrically inoculate three infant
mice as above. Twenty-four hr postinfection, mice were euthanized,
their small bowels were removed and homogenized in 1 ml of saline.
The three homogenates of each strain were combined and filtered
through a 100 mm cell strainer. Filtrate of each competing strain
(150 ml) was mixed together with 700 ml saline and used as inoculum
(53 106 CFU/ml) in various fitness assays performed in 96-well poly-
sterene plates (Costar). For survival in filtered rice-water stool, 10 ml of
the inoculum was mixed with 100 ml of stool and incubated for 2 hr at
25C. In all other assays, 10 ml of inoculum was diluted in 100 ml saline
and then diluted a further 1/10 and 1/100 in test solution and incubated
for 24 hr at 25C. For reinfection, 50 ml of the inoculum was used to
intragastrically inoculate infant mice as described above.
In all cases, incubation in LBwas used as a control. After incubation,
serial dilutions were plated on LB-Sm/X-Gal plates. The results are
shown as the CI as described above.
We also determined the fitness in transition assays without prior in
vivo passage of the competing strains. In this case, strains were grown
on LB-Sm plates O/N, diluted in saline to OD600 = 0.2, mixed 1:1 and
diluted to OD600 = 0.02 (5 3 106 CFU/ml), and used as the inoculum
as described above.
Collection and Preparation of Stool and Pond Water Samples
Rice-water stool samples were collected from patients (>15 years of
age) in Bangladesh with acute watery diarrhea and no prior treatment
with antibiotics during a 2006 spring outbreak. The two samples in-
cluded in this study were selected on the basis of positive culture for
V. cholerae O1 and negative tests for lytic vibriophage and enterotoxi-
genic E. coli, each assayed by standard methodology. Upon collec-
tion, stool supernatants were prepared by centrifugation at 15,000
rpm for 15 min at 4C, filtration of the supernatant through a 0.22 mM
polystyrene filter (Millipore), and stored at 80C. The protocol for
the collection of these samples was approved by the Research Review
Committee and the Ethical ReviewCommittee at the International Cen-
tre for Diarrheal Disease Research in Bangladesh and by the Human
Research Committee at the Massachusetts General Hospital. Pond
water from Dhaka, Bangladesh and Boston, Massachusetts was fil-
tered through a 0.45 mM polystyrene filter (Millipore) and frozen at
80C. All pond water samples used tested negative for lytic vibrio-
phage. Both pond water samples had similar chemical compositions
(Table S3).
Supplemental Data
The Supplemental Data include Supplemental Experimental Proce-
dures, three supplemental tables, and one supplemental figure and
can be foundwith this article online at http://www.cellhostandmicrobe.
com/cgi/content/full/2/4/264/DC1/.
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